产品封面图

Anti-HAstV-1 Spike Protein Ant

ibody (3B4), 抗HAstV-1Spike Protein抗体 (3B4)
收藏
  • ¥1668
  • abinScience
  • China
  • VK035023
  • 2026年03月03日
  • ELISA, Neutralization
  • Human
  • HAstV-1
avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      Human

    • 亚型

      IgG

    • 形态

      Liquid

    • 保存条件

      0.01M PBS pH 7.4

    • 克隆性

      Monoclonal

    • 标记物

      Unconjugated

    • 适应物种

      HAstV-1

    • 保质期

      1 year

    • 抗原来源

      Human

    • 目录编号

      VK035023

    • 级别

      科研级别

    • 库存

      999

    • 供应商

      abinScience

    • 宿主

      Human

    • 应用范围

      ELISA, Neutralization

    • 浓度

      1mg/mL

    • 靶点

      Capsid polyprotein VP90, Capsid polyprotein VP70, Core protein VP34, Spike protein VP27, Spike protein VP25

    • 抗体英文名

      Anti-HAstV-1 Spike Protein Antibody (3B4)

    • 抗体名

      Anti-HAstV-1 Spike Protein Antibody (3B4)

    • 规格

      100ul

    产品细节图片1

    Product nameAnti-HAstV-1 Spike Protein Antibody (3B4)
    Catalog No.VK035023
    Host speciesHuman
    Species reactivityHAstV-1
    Immunogen/
    FormLiquid
    Storage buffer0.01M PBS pH 7.4
    Purity>95% as determined by SDS-PAGE.
    ClonalityMonoclonal
    IsotypeIgG
    ApplicationsELISA, Neutralization
    TargetCapsid polyprotein VP90, Capsid polyprotein VP70, Core protein VP34, Spike protein VP27, Spike protein VP25
    PurificationProtein A/G purified from cell culture supernatant.
    Endotoxin levelPlease contact with the lab for this information.
    Expression system/
    AccessionO12792
    Alternative Names/
    Clone ID3B4
    Species/
    Product Usage Information/

    abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.

     

    Technology and Innovation

    Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for abinScience's product research and development.

     

    Product categories and application fields.

    Main products.
    10000+ high-activity proteins.
    15000+ antibody series products:
    Classic monoclonal antibody.
    Monoclonal antibody
    Internal control antibody, labeled antibody.
    High-quality phosphorylation antibodies.
    Highly specific nanobodies and small molecule antibodies.
    Functional antibodies in vivo.
    Low-background flow cytometry antibodies.
    DNA/RNA antibodies and PEG antibodies.
    1000+ reagent kit series products.
    Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.


    Application field

    Infectious disease research: including viruses, superbugs, parasites, etc.
    Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
    Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
    Oncology research: Supporting the development of tumor biology and anti-tumor drugs.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • Pseudotyped Vesicular Stomatitis Virus for Analysis of Virus Entry Mediated by SARS Coronavirus Spike Proteins

      ). Partial deletion of the cytoplasmic domain of SARS-CoV S protein (SARS-CoV-St19) allowed efficient incorporation into the VSV particle that enabled the generation of a high titer of pseudotype virus. Neutralization assay with anti-SARS-CoV antibody

    • 从血浆疗法到抗体疫苗,战胜新冠肺炎,或许不用等太久了!

      识别新型冠状病毒上的关键抗原表位。复旦大学应天雷教授团队在 Emerging Microbes & Infections 杂志在线发表题为《Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody》的研究论文,报道了一种新型冠状病毒特异性的人单克隆抗体 —CR3022,可与新型冠状病毒受体结合域 RBD 结合,具有发挥预防和治疗新型

    • 常用抗体的应用范围及选用方案

      癌,胸腺癌等部分阳性。但是,该 抗体只能用于冰冻切片 ,涂片和细胞培养片。不能用于石蜡切片 。 ④单克隆小鼠 人细胞角蛋白,克隆34BE12。该 抗体属于高分子量类型,它可检测鳞状上皮管上皮和 复层上皮的组织及其来源的肿瘤。 适用范围:可用于各种类型的切片 。 2. 单克隆小鼠抗人上皮细胞膜抗原 (Monoclonal mose anti human epithelial memberance antigen,EMA) 上皮细胞膜抗原是上皮细胞表面大分

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    维百奥(北京)生物科技有限公司
    2026年03月16日询价
    ¥1668
    普健生物(武汉)科技有限公司
    2026年03月03日询价
    ¥806
    广州市左克生物科技发展有限公司
    2026年03月26日询价
    ¥1680
    上海圻明生物科技有限公司
    2025年12月22日询价
    Anti-HAstV-1 Spike Protein Antibody (3B4), 抗HAstV-1Spike Protein抗体 (3B4)
    ¥1668